0001562180-22-005608.txt : 20220706 0001562180-22-005608.hdr.sgml : 20220706 20220706200709 ACCESSION NUMBER: 0001562180-22-005608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20220706 DATE AS OF CHANGE: 20220706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russell Kerry Strong CENTRAL INDEX KEY: 0001927137 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39926 FILM NUMBER: 221070391 MAIL ADDRESS: STREET 1: C/O TERNS PHARMACEUTICALS, INC. STREET 2: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001831363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-525-5535 EXT.101 MAIL ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-07-01 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001927137 Russell Kerry Strong C/O TERNS PHARMACEUTICALS, INC. 1065 E. HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 false true false false Chief Medical Officer Stock Option (Right to Buy) 2.69 2022-07-01 4 A false 240000.00 0.00 A 2032-06-30 Common Stock 240000.00 240000.00 D 25% of the shares subject to the option vest on the first anniversary measured from May 31, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. /s/ Bryan Yoon, as Attorney-in-Fact for Kerry Strong Russell 2022-07-06